Related Experiment Video
Updated: Jun 10, 2026

Detection of DNA Double-Stranded Breaks in Mouse Oocytes
Published on: June 23, 2023
Doxorubicin-induced apoptosis in germinal vesicle (GV) oocytes
Hadas Bar-Joseph1, Irit Ben-Aharon, Shulamith Rizel
1Department of Cell and Developmental Biology, Sackler Faculty of Medicine, Tel-Aviv University, Ramat-Aviv, Tel-Aviv, Israel.
Abstract:
Ovarian failure is a-known side-effect observed in women treated for cancer. Doxorubicin (DXR) was found to be detrimental to MII mouse oocytes. We aimed at characterizing the effect of DXR on germinal vesicle (GV) oocytes that comprise the majority of oocytes within ovaries encountering chemotherapy. Mouse follicles and oocytes were exposed to DXR in vitro. DXR localization and its possible cellular targets were examined by fluorescence confocal microscopy. We demonstrated that DXR crosses the blood-follicle barrier and accumulates in oocytes and granulosa cells. The mechanism of DXR-induced apoptosis involves chromosomal disintegration, activation of the mitochondria followed by activation of PERK and caspase-12 and inactivation of PARP. The follicular GV oocytes were more vulnerable to the toxic effect of DXR than ovulated MII oocytes. We suggest that DXR elicits apoptotic signal within GV oocytes that involves activation of the mitochondria, induction of ER-stress and a possible increase in intracellular calcium.
Insights
Doxorubicin (DXR) chemotherapy harms ovarian germinal vesicle (GV) oocytes by crossing the blood-follicle barrier and triggering apoptosis. These GV oocytes are more vulnerable than MII oocytes, impacting fertility in cancer survivors.
Area of Science:
- Reproductive Biology
- Cancer Therapeutics
- Cellular Toxicology
Background:
- Ovarian failure is a recognized side effect of cancer treatment.
- Doxorubicin (DXR) is a chemotherapy agent known to harm oocytes.
- Germinal vesicle (GV) oocytes represent the majority of ovarian oocytes during chemotherapy exposure.
Purpose of the Study:
- To characterize the effects of Doxorubicin (DXR) on germinal vesicle (GV) oocytes.
- To investigate DXR's mechanism of toxicity in ovarian follicles.
- To assess the vulnerability of GV oocytes compared to MII oocytes.
Main Methods:
- In vitro exposure of mouse follicles and oocytes to DXR.
- Fluorescence confocal microscopy for DXR localization and cellular target identification.
- Analysis of apoptotic pathways, including mitochondrial activation, PERK, caspase-12, and PARP.
Main Results:
- DXR penetrates the blood-follicle barrier and accumulates in oocytes and granulosa cells.
- DXR induces apoptosis in GV oocytes via chromosomal disintegration, mitochondrial activation, ER-stress (PERK, caspase-12), and PARP inactivation.
- Follicular GV oocytes exhibit greater sensitivity to DXR toxicity than ovulated MII oocytes.
Conclusions:
- DXR triggers an apoptotic cascade in GV oocytes involving mitochondrial and endoplasmic reticulum (ER) stress.
- The study elucidates DXR's mechanism of ovarian toxicity, highlighting GV oocyte vulnerability.
- Findings suggest DXR-induced ER-stress and potential intracellular calcium increase contribute to oocyte apoptosis.
Related Concept Videos
Apoptosis
In vitro Mutagenesis

